
Developing a Vaccine Against Nipah Virus
When One Drug Fails, A New Door Opens For Cancer Treatment
A new class of cancer drugs called CDK4/6 inhibitors, recently approved to treat breast cancer, can stunt the cancer’s growth and replication. It is also being explored for a number of other cancers. Unfortunately, patients often develop resistance to the therapy, and the cause of that resistance has been difficult to pin down. Researchers at the Sidney Kimmel…
CAR-T Immunotherapy Eliminates Metastatic Colorectal Cancer in Mice
New Targeted Therapy Schedule Could Keep Melanoma at Bay
Buprenorphine Cuts Length of Stay Nearly in Half for Infants Withdrawing from Opioids
Babies born to women who have used opioids at any point during pregnancy are at risk of suffering withdrawal symptoms – collectively called neonatal abstinence syndrome (NAS) – that can cause serious problems in the infant. To reduce the severity of these symptoms, infants are treated with opioids and then slowly weaned off over the…
Diabetes Drug Takes Aim at Cancer’s Fuel Source
Natural Molecule Could Improve Parkinson’s
The natural molecule, n-acetylcysteine (NAC), with strong antioxidant effects, shows potential benefit as part of the management for patients with Parkinson’s disease, according to a study published today in the journal PLOS ONE. Combining clinical evaluations of a patient’s mental and physical abilities with brain imaging studies that tracked the levels of dopamine, the lack…